Evidence-based assessment/Vignettes/Jay
HGAPS is finding new ways to make psychological science conferences more accessible!
Here are examples from APA 2022 and the JCCAP Future Directions Forum. Coming soon... ABCT!
~ More at HGAPS.org ~
Jay
[edit | edit source]Clinical description
[edit | edit source]Jay is a 22-year-old male undergraduate student at the University of North Carolina at Chapel Hill (UNC). Jay was previously diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD). In college, Jay complained of having difficulties with sustaining attention, reading, inadequate study habits, and poor performance in his college courses (relative to his high school performance). He has been experiencing mood fluctuations. Jay has been feeling anxious for a long time. He says that he has "panic attacks" and "persistent worrying."
History of presenting a problem
[edit | edit source]Jay had previously been evaluated for Attention-Deficit/Hyperactivity Disorder (ADHD) and was diagnosed. In addition to attention and reading difficulties, Jay reported clinically significant disordered mood and fluctuations in mood (i.e., periods of “highs” and “lows”), and a strong family history of bipolar disorder. Finally, Jay reported a longstanding history of anxiety, including panic attacks and persistent worrying.
Conceptualization
[edit | edit source]
Initial treatment plan
[edit | edit source]Assessment Findings
[edit | edit source]Checklist Scores
[edit | edit source]Extended content
|
---|
Select more specialized scales to refine probabilities[edit | edit source]Updating probabilities[edit | edit source]Critical items[edit | edit source] |
Diagnostic Interview findings
[edit | edit source]Cognitive and Achievement Testing
[edit | edit source](Not done as part of the evaluation; may be able to match up information later)
Let's see how we would apply the EBA principles to Arlene:
Shortlist of Probable Hypotheses
[edit | edit source]Based on Jay's age and the common clinical issues, here are the possible issues:
- Attention problems
- Anxiety disorders
- Substance misuse should be another hypothesis, based again on its prevalence in his age group.
- A mood disorder
Could add table with DLRS and revised probabilities, or leave them blank and have a "key" section?
Jay | Common Dx Hypotheses (A) | Starting Prob. (B) | Broad Measure (D) | Cross-informant (E) | Confirmation (G) | Treatment Phase (I), (J), (K) | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Base Rate from Kessler et al. (2005) NCS-R | Scale & Score | DLR | Revised Prob. | EAY Check | Next Test score | DLR | Revised Prob. | MINI | |||
Specific Phobia | 0.13 | ||||||||||
PTSD | 0.06 | ||||||||||
GAD | 0.04 | Generalized Anxiety Disorder Current | |||||||||
Panic Disorder | 0.04 | Panic Disorder Lifetime | |||||||||
Social Phobia | 0.14 | ||||||||||
Separation Anxiety | 0.02 | ||||||||||
Any Impulse Control Disorder | ODD | 0.10 | |||||||||
CD | 0.11 | ||||||||||
ADHD | 0.08 | Adult ADHD | |||||||||
Any Mood Disorder | MDD | 0.15 | BDI | Major Depressive Episode w/ Melancholic Features, Past | |||||||
BP | 0.06 | MDQ | KSADS Mania Scale? | Hypomanic Episode | |||||||
Dysthymia | 0.02 | ||||||||||
Any Substance Abuse Disorder | 0.17 |
Answers | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Mention that these have DLRs. Also unpack the implications of agreement and disagreement for the client (and add a section about treatment implications of disagreement on the Conceptual Model Pages)
Mental Status and Clinical Observations
[edit | edit source]add content
Reliable Change Index
[edit | edit source]Pick a treatment target and specify what the RCI would be for it. Discuss how you would explain to Arlene
Nomothetic Benchmarks
[edit | edit source]A, B, Cs of Jacobson definitions. General stuff about limitations would go on the main concept page. Here it is focused on the client -- what are the benchmarks they will focus on? How explained to them?
Interpreting benchmarks
[edit | edit source]Minimum Important Difference (MID)
[edit | edit source]Note that this section is a dangler -- not originally called out in the 12 steps. Medium d as a rule of thumb from Streiner, Norman, & Cairney (2015). Could work from AUC to d to raw units as a way of estimating, since psychology hasn't done research on this yet. Might be able to back into it with studies that had CSQ and outcome data.
Client Goals & Tracking
[edit | edit source]These would be personal goals and idiographic measurement -- YTOPS, etc.
This would be traces such as coming to sessions, doing homework assignments. (Not sure of other specifics involved in current IPT protocols?)
YTOPS again and goal setting.
Revisit Jacobson benchmarks. Is there much chance of relapse? What things would the client need to pay attention to if they were going to nip that in the bud?
- ↑ Merikangas, Kathleen Ries; He, Jian-ping; Burstein, Marcy; Swanson, Sonja A.; Avenevoli, Shelli; Cui, Lihong; Benjet, Corina; Georgiades, Katholiki et al.. "Lifetime Prevalence of Mental Disorders in U.S. Adolescents: Results from the National Comorbidity Survey Replication–Adolescent Supplement (NCS-A)". Journal of the American Academy of Child & Adolescent Psychiatry 49 (10): 980–989. doi:10.1016/j.jaac.2010.05.017. PMID 20855043. PMC PMC2946114. https://dx.doi.org/10.1016/j.jaac.2010.05.017.